Literature DB >> 21677334

Anatomical cardiac alterations in liver cirrhosis: an autopsy study.

Nayeli X Ortiz-Olvera1, Guillermo Castellanos-Pallares, Luz M Gómez-Jiménez, María L Cabrera-Muñoz, Jorge Méndez-Navarro, Segundo Morán-Villota, Margarita Dehesa-Violante.   

Abstract

BACKGROUND: It has been suggested that liver cirrhosis (LC), regardless of etiology, may be associated with anatomical cardiac alterations.
OBJECTIVE: To describe the frequency and type of macroscopical anatomic cardiac abnormalities present in alcoholic and non-alcoholic cirrhotic patients in an autopsy series.
MATERIAL AND METHODS: The autopsy records performed at our institution during a 12-year period (1990-2002) were reviewed. All cases with final diagnosis of LC were included, their demographic characteristics as well as cirrhosis etiology and macroscopic anatomical cardiac abnormalities (MACA) analyzed. Patients with any known history of heart disease prior to diagnosis of cirrhosis were excluded.
RESULTS: A total of 1,176 autopsies were performed, of which 135 cases (11.5%) were patients with LC. Two patients with cardiac cirrhosis were excluded. Chronic alcohol abuse (29%) and chronic hepatitis due to hepatitis C virus (HCV) infection (20%) were the most common causes of cirrhosis. The etiology was not identified in 35% of the cases, even after exhaustive clinical, serological and/or radiological assessment. In the postmortem analysis, 43% of the cases were informed to have MACA (47% in the group of patients with alcoholic cirrhosis and 41% in other types of cirrhosis); this rate increased to 62% in patients with ascites. The most frequent alterations were cardiomegaly and left ventricular hypertrophy (LVH).
CONCLUSION: The results confirm the high frequency of cardiac abnormalities in patients with cirrhosis, regardless of cirrhosis etiology.

Entities:  

Mesh:

Year:  2011        PMID: 21677334

Source DB:  PubMed          Journal:  Ann Hepatol        ISSN: 1665-2681            Impact factor:   2.400


  14 in total

1.  Cardiac changes in pediatric liver transplant recipients: are they truly irreversible?

Authors:  Florence Wong
Journal:  Hepatol Int       Date:  2016-02-16       Impact factor: 6.047

Review 2.  Does cirrhotic cardiomyopathy exist? 50 years of uncertainty.

Authors:  Pierpaolo Pellicori; Concetta Torromeo; Angela Calicchia; Alessandra Ruffa; Martina Di Iorio; John G F Cleland; Manuela Merli
Journal:  Clin Res Cardiol       Date:  2013-09-01       Impact factor: 5.460

3.  The impact of left ventricular hypertrophy on survival in candidates for liver transplantation.

Authors:  Sachin Batra; Victor I Machicao; John S Bynon; Shivang Mehta; Rajasekhar Tanikella; Michael J Krowka; Steven Zacks; James Trotter; Kari E Roberts; Robert S Brown; Steven M Kawut; Michael B Fallon
Journal:  Liver Transpl       Date:  2014-06       Impact factor: 5.799

Review 4.  [Hepatocardiac disorders : Interactions between two organ systems].

Authors:  T Horvatits; A Drolz; K Rutter; K Roedl; S Kluge; V Fuhrmann
Journal:  Med Klin Intensivmed Notfmed       Date:  2015-06-13       Impact factor: 0.840

Review 5.  Echocardiography in the Liver Transplant Patient.

Authors:  Parul Kakar; James Gubitosa; Christine Gerula
Journal:  Curr Cardiol Rep       Date:  2021-07-03       Impact factor: 2.931

Review 6.  B-type peptides to predict post-liver transplant mortality: systematic review and meta-analysis.

Authors:  Daljeet Chahal; Alan Yau; Paola Casciato; Vladimir Marquez
Journal:  Can Liver J       Date:  2019-02-25

7.  Cardiac remodelling identified by cardiovascular magnetic resonance in patients with hepatitis C infection and liver disease.

Authors:  Phillip J Ngu; Michelle Butler; Alan Pham; Stuart K Roberts; Andrew J Taylor
Journal:  Int J Cardiovasc Imaging       Date:  2015-12-15       Impact factor: 2.357

8.  Diagnosis and Management of Cirrhotic Cardiomyopathy.

Authors:  Harpreet Kaur; Madhumita Premkumar
Journal:  J Clin Exp Hepatol       Date:  2021-08-21

9.  Systemic vascular resistance and fluid status in patients with decompensated liver cirrhosis with or without functional renal failure in Egypt.

Authors:  Ashraf Abd El-Khalik Barakat; Fatma Mohammad Nasr; Amna Ahmed Metwaly; Maged El-Ghannam
Journal:  Electron Physician       Date:  2015-08-10

Review 10.  Recent advances in the diagnosis and management of cirrhosis-associated cardiomyopathy in liver transplant candidates: advanced echo imaging, cardiac biomarkers, and advanced heart failure therapies.

Authors:  Maryjane Farr; Paul Christian Schulze
Journal:  Clin Med Insights Cardiol       Date:  2015-01-28
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.